Topiramate

Specifications

97240-79-4CAS Number

619-263-3EC Number

[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamateIUPAC Name

C12H21NO8SChemical Formula

339.36 g/molMolecular Weight

topiramate; 97240-79-4; Topamax; Epitomax; Topamax Sprinkle; Topina; Tipiramate; Topiramato; Topiramatum; Topimax; Topomax; McN-4853; Tipiramato; Epitoma; Topamac; RWJ-17021; RWJ-17021-000; Sincronil; Qudexy; Trokendi XR; Qudexy XR; USL255; 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate; (-)-topiramate; DTXSID8023688; USL-255; EPRONTIA; 2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate; 0H73WJJ391; DTXCID103688; CHEBI:63631; QSYMIA COMPONENT TOPIRAMATE; beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate; [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate; topiramate tablet; [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0^{2,6}]dodecan-6-yl]methyl sulfamate; McN4853; topiramate spinkle; ((1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo(7.3.0.0^(2,6))dodecan-6-yl)methyl sulfamate; ((1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo(7.3.0.02,6)dodecan-6-yl)methyl sulfamate; ((3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi(1,3)dioxolo(4,5-a:5',3'-d)pyran-3a-yl)methyl sulfamate; [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate; RefChem:56737; 2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate; N03AX11; MFCD00865320; C12H21NO8S; ((3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl sulfamate; [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate; Tipiramate [French]; Tipiramato [Spanish]; Topiramatum [INN-Latin]; topiramatum [Latin]; Topiramato [INN-Spanish]; McN 4853; TPM; Topiragen; Topax; SMR000466325; Topiramate (TPM); TOR; Topamax (TN); CAS-97240-79-4; BRN 5988957; UNII-0H73WJJ391; Topiramate CRS; HSDB 7531; McN 4853;RWJ 17021; Sulfamate 7; 3hku; 3lxe; USL 255; Topiramate [USAN:USP:INN:BAN]; NCGC00095181-01; ((3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl)methyl sulfamate; Trokendi xr (TN); KS-1122; Topiramate (Standard); TOPIRAMATE [MI]; TOPIRAMATE [INN]; TOPIRAMATE [JAN]; Spectrum2_001128; TOPIRAMATE [HSDB]; TOPIRAMATE [USAN]; TOPIRAMATE [VANDF]; CBChromo1_000352; TOPIRAMATE [MART.]; TOPIRAMATE [USP-RS]; TOPIRAMATE [WHO-DD]; BIDD:PXR0127; SCHEMBL34631; BSPBio_002306; Topiramate (JAN/USP/INN); Eprontia (liquid formulation); MLS000759431; MLS001424070; BIDD:GT0854; SPECTRUM1505801; SPBio_000995; CHEMBL220492; GTPL6849; orb1223497; orb1310396; orb3141281; TOPIRAMATE [ORANGE BOOK]; BDBM10887; HY-B0122R; TOPIRAMATE [EP MONOGRAPH]; TOPIRAMATE [USP IMPURITY]; HMS1922H06; HMS2051L09; HMS2093D20; HMS2232H21; HMS3414C15; HMS3678C15; HMS3715I12; HMS3884C17; Pharmakon1600-01505801; TOPIRAMATE [USP MONOGRAPH]; [(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate (non-preferred name); ALBB-022457; HY-B0122; MSK10313; Topiramate, 1mg/ml in Acetonitrile; Tox21_111472; Tox21_302401; EBC-07086; HB0618; NSC759251; .beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate; AKOS000424547; Topiramate 1.0 mg/ml in Acetonitrile; Topiramate, >=98% (HPLC), solid; Tox21_111472_1; CCG-100940; CS-1885; DB00273; MD03549; NC00190; NSC 759251; NSC-759251; NCGC00178714-01; NCGC00178714-02; NCGC00178714-04; NCGC00178714-18; NCGC00255221-01; SY028640; SBI-0206907.P001; NS00010259; SW197570-3; C07502; D00537; EN300-118319; F20536; AB00639961-06; AB00639961-08; AB00639961_09; AB00639961_10; F372976; Q221174; SR-01000759409; W-60376; SR-01000759409-4; BRD-K29653726-001-13-4; BRD-K29653726-001-14-2; BRD-K29653726-001-15-9; Z1511495258; Topiramate, United States Pharmacopeia (USP) Reference Standard; 2,3:4,5-Bis-O-(1-methylethylidene) ?-D-fructopyranose sulfamate; 2,3:4,5-DI-O-ISOPROPYLIDENE-.BETA.-D-FRUCTOPYRANOSE SULFAMATE; Topiramate, Pharmaceutical Secondary Standard; Certified Reference Material; .beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-sulfamate; [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0,2,6]dodecan-6-yl]methyl sulfamate; [(3aS,5aR,8aR,8bS)-2,2,7,7-Tetramethyltetrahydro-2H,3aH,7H-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamateSynonyms